Australia's largest stock trading and investment forum Australia's #1 stock forum

BOT

Click for more information

2.86%

36.0¢ botanix pharmaceuticals ltd

Absolutely agree. Great point!

First 150 Last

Share
Profile

Follow
rusty388

502 Posts.

113

06/03/19

12:29

Post #: 37670277
Share

Originally posted by Fela ↑

Agree with the positive view on Matt Callahan. But in pharma companies aiming to get new drugs registered - the key person is often the head of Regulatory Affairs. They would be the person in the room the FDA would probably want to talk to - and the person in the room they would be most likely to listen to.

So - glancing through an old slide deck - I was really happy to see Judith Plon now heading up Reg Affairs for Botanix. This is not just someone who knows the landscape and comes with huge amounts of experience - but most likely she was instrumental in getting Sanofi's new biologic FDA approval back in March 2017. Dupixent is the first biologic approved for use of atopic dermatitis.

(BTW - in my opinion biologics are unlikely to compete with Botanix - they are typically reserved for very severe cases - and cost a fortune so tend to be significantly limited in use as a result. Adverse events can also read like a Stephen King novel at times - so different area of need altogether.)

So - not only do we have a star performer at the helm - but Matt certainly knows how to pick a winning team - and one that has recent experience in getting 'breakthrough' drugs approved by the FDA.

Expand

Absolutely agree. Great point!

BOT Price at posting: 12.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

AJJ

Photovoltaic glass player ClearVue buys Agritech company; eyes greenhouses

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

There are more pages in this discussion • 10 more messages in this thread...

First 150 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 36.0¢		Change 0.010(2.86%)		Mkt cap ! $707.4M

Open	High	Low	Value	Volume
35.0¢	36.0¢	34.5¢	$427.9K	1.212M

Buyers (Bids)

No.	Vol.	Price($)
6	341767	35.5¢

Sellers (Offers)

Price($)	Vol.	No.
36.0¢	1051751	18

View Market Depth

No.	Vol.	Price($)
11	423267	0.105
23	1189777	0.100
1	10111	0.099
1	50000	0.098
1	50000	0.097

Price($)	Vol.	No.
0.110	555657	10
0.115	560304	6
0.120	829451	14
0.125	1083838	12
0.130	498290	12

Last trade - 10.39am 28/11/2024 (20 minute delay)

BOT (ASX) Chart